期刊文献+

术前经新辅助治疗的中低位直肠癌患者吻合口漏的预防和治疗 被引量:12

Anastomotic leakage in patients with lower rectal cancer receiving preoperative neoadjuvant therapy
原文传递
导出
摘要 目的探讨中低位直肠癌新辅助治疗后吻合口漏的预防和治疗。方法回顾性分析2004年8月至2007年7月间50例低位直肠癌采用新辅助治疗保肛术后,吻合口漏的发生及治疗情况。结果50例患者接受FOLFOX方案联合放疗的新辅助治疗后接受保肛手术。行预防性回肠末段造口的19例患者未发生吻合口漏,31例未行预防性回肠末段造口术中有4例术后发生吻合口漏,其中2例合并直肠阴道瘘,均经保守治疗治愈。结论FOLFOX方案联合放疗的新辅助治疗,可提高中低位直肠癌手术的保肛率,保肛术后行回肠末段预防性造口,对吻合口漏的发生有预防作用。 Objective To investigate the prevention and management of anastomotic leakage in patients with middle and lower rectal cancer after neoadjuvant therapy. Methods In this study, 50 cases of middle or lower rectal carcinoma underwent anus preserving radical resection and anastomosis after a 4 cycles of chemotherapy with FOLFOX and 46 Gy ( 2 Gy × 23 ) radiotherapy. Anastomotic leakage, the prevention and management of this complication were analyzed retrospectively. Results All these 50 patients received low anterior resection after chemoradiotherapy, among the 19 cases receiving prophylactic ileac stoma simultaneously, there was no anastomotic leakage, whereas anastonlotic leakage developed in 4 out of the 31 patients who did not receive prophylactic ileac stoma, including concomitant rectovaginal fistula in 2 cases. All these fistulae were cured conservatively. Conclusion Concomitant treatment of FOLFOX regimen and RT in neoadjuvant setting of rectal cancer could increase the rate of anal interior sphincter reservation, prophylactic ileac stoma helps to reduce the rate of anastomotic leakage after a anus-preserving low anterior resection of the cancer.
出处 《中华普通外科杂志》 CSCD 北大核心 2009年第2期100-102,共3页 Chinese Journal of General Surgery
关键词 直肠肿瘤 肿瘤辅助疗法 手术后并发症 吻合口漏 Rectal neoplasm Neoadjuvant therapy Postoperative complications Anastomotic leakage
  • 相关文献

参考文献8

  • 1汪建平,丁卫星,邓艳红,兰平,潘凯,董功航,邓建中,王磊,吴小剑,郭学锋,郑洁.FOLFOX方案联合放疗的新辅助治疗在低位直肠癌中的临床多中心研究[J].中华胃肠外科杂志,2008,11(2):116-119. 被引量:19
  • 2Collette L, Bosset JF, den Dulk M, et al. Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trail of the European Organization for research and treatment of Cancer Radiation Oncology Group. J Clin Oncol, 2007,25:4379-4386. 被引量:1
  • 3Goldberg RM, Tabah-Fisch I, Bleiberg H, et al. Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer. J Clin Oncol, 2006,24:4085-4091. 被引量:1
  • 4Rodriguez-Ramirez SE, Uribe A, Ruiz-Garcia EB, et al. Risk factors for anastomotic leakage after preoperative chemoradiation therapy and low anterior resection with total mesorectal excision for locally advanced rectal cancer. Rev Invest Clin, 2006,5$: 204-210. 被引量:1
  • 5Giuliani D, Willemsen P, Van Elst F, et al. A defunctioning stoma in the treatment of lower third rectal carcinoma. Acta Chir Belg, 2006,106:4043. 被引量:1
  • 6Valenti V, Hemandez-Lizoain JL, Baixauli J, et al. Analysis of early postoperative morbidity among patients with rectal cancer treated with and without neoadjuvant ehemoradiotherapy. Ann Surg Oncol, 2007,14 : 1744-1751. 被引量:1
  • 7Wichmann MW, Meyer G, Adam M, et al. Detrimental immunologic effects of preoperative chemoradiotherapy in advanced rectal cancer. Dis Colon Rectum, 2003,46:875-887. 被引量:1
  • 8Widder J, Herbst F, Dobrowsky W, et al. Preoperative short- term radiation therapy (25 Gy, 2.5 Gy twice daily) for primary resectable rectal cancer (phase II). Br J Cancer, 2005,92: 1209-1214. 被引量:1

二级参考文献11

  • 1邓艳红,詹文华.结直肠癌新辅助治疗的新进展[J].中国实用外科杂志,2005,25(5):310-312. 被引量:21
  • 2徐宗斌,林惠铭,池畔.腹腔镜与开腹中低位直肠癌保肛手术后并发症的比较[J].肿瘤学杂志,2006,12(1):50-53. 被引量:9
  • 3邓艳红,兰平.综合治疗对中低位直肠癌功能保护的意义[J].中华胃肠外科杂志,2007,10(4):396-398. 被引量:4
  • 4Lam CW, Chen WT, Liu Mr, et al. Effect of preoperative concurrent chemoradiotherapy in locally advanced low rectal cancer after radical resection surgery. Int Surg, 2005,90:53-59. 被引量:1
  • 5Karakiewicz PI, Trlnh QD, de la Taille A, et al. ECOG performance status 0 or 1 and symptom classification do not improve the ability to predict renal cell carcinoma-speclfic survival. Eur J Cancer, 2007,43 : 1023-1029. 被引量:1
  • 6Frei E.3rd. Clinical cancer research: an embattled species. Cancer, 1982,50 : 1979-1992. 被引量:1
  • 7Wilke H, Preusser P, Fink U, et al. Preoperative chemotherapy in locally advanced and nonresectable gastric cancer:a phase Ⅱ study with etoposide,doxorubicin,and eisplatin. J Clin Oncol, 1989,7:1318-1326. 被引量:1
  • 8Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med, 2004, 351 : 1731-1740. 被引量:1
  • 9Gerard JP, Chapet O, Nemoz C, et al. Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R0-04 phase Ⅱ trial. J Clin Oncol, 2003,21:1119- 1124. 被引量:1
  • 10Fakih MG, Rajput A, Yang GY, et al. A phase I study of weekly intravenous oxaliplatin in combination with oral daily capecitabine and radiation therapy in the neoadjuvant treatment of rectal adenocarcinoma. Int J Radiat Oncol Biol Phys, 2006,65 : 1462-1470. 被引量:1

共引文献18

同被引文献96

引证文献12

二级引证文献107

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部